Pediatric AML: From Biology to Clinical Management

Pediatric acute myeloid leukemia (AML) represents 15%–20% of all pediatric acute leukemias. Survival rates have increased over the past few decades to ~70%, due to improved supportive care, optimized risk stratification and intensified chemotherapy. In most children, AML presents as a de novo entity...

Descripción completa

Detalles Bibliográficos
Autores principales: de Rooij, Jasmijn D. E., Zwaan, C. Michel, van den Heuvel-Eibrink, Marry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470244/
https://www.ncbi.nlm.nih.gov/pubmed/26237023
http://dx.doi.org/10.3390/jcm4010127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470244/
https://www.ncbi.nlm.nih.gov/pubmed/26237023
http://dx.doi.org/10.3390/jcm4010127

Ejemplares similares